ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 255 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $236,397,168 | -4.9% | 17,990,652 | -8.8% | 0.01% | 0.0% |
Q2 2023 | $248,480,543 | -6.9% | 19,720,678 | -3.6% | 0.01% | -12.5% |
Q1 2023 | $266,992,392 | -27.6% | 20,459,187 | -2.1% | 0.01% | -33.3% |
Q4 2022 | $368,727,897 | +16.3% | 20,902,942 | +0.4% | 0.01% | +9.1% |
Q3 2022 | $317,155,000 | +1.4% | 20,824,290 | -1.3% | 0.01% | +10.0% |
Q2 2022 | $312,810,000 | -39.6% | 21,093,091 | -8.3% | 0.01% | -28.6% |
Q1 2022 | $517,979,000 | +17.7% | 23,000,787 | -3.5% | 0.01% | +27.3% |
Q4 2021 | $439,969,000 | +50.8% | 23,846,502 | +9.3% | 0.01% | +37.5% |
Q3 2021 | $291,710,000 | -35.7% | 21,818,383 | -11.0% | 0.01% | -38.5% |
Q2 2021 | $453,932,000 | +23.0% | 24,523,533 | -0.2% | 0.01% | +18.2% |
Q1 2021 | $369,094,000 | +3.3% | 24,581,704 | -0.6% | 0.01% | 0.0% |
Q4 2020 | $357,160,000 | +70.4% | 24,734,113 | -3.9% | 0.01% | +37.5% |
Q3 2020 | $209,597,000 | +14.6% | 25,749,058 | -4.7% | 0.01% | +14.3% |
Q2 2020 | $182,921,000 | +24.5% | 27,019,701 | +29.5% | 0.01% | 0.0% |
Q1 2020 | $146,934,000 | -29.4% | 20,871,494 | -1.5% | 0.01% | -12.5% |
Q4 2019 | $208,078,000 | -11.6% | 21,200,086 | -1.1% | 0.01% | -20.0% |
Q3 2019 | $235,277,000 | +4.1% | 21,427,801 | +10.3% | 0.01% | 0.0% |
Q2 2019 | $225,993,000 | +17.0% | 19,432,061 | -4.0% | 0.01% | +11.1% |
Q1 2019 | $193,188,000 | -1.7% | 20,250,462 | -0.7% | 0.01% | -10.0% |
Q4 2018 | $196,579,000 | -31.3% | 20,392,048 | +1.6% | 0.01% | -16.7% |
Q3 2018 | $286,027,000 | +18.0% | 20,072,189 | -0.7% | 0.01% | +9.1% |
Q2 2018 | $242,462,000 | +0.0% | 20,205,195 | +2.9% | 0.01% | -8.3% |
Q1 2018 | $242,389,000 | -13.7% | 19,626,646 | +1.6% | 0.01% | -7.7% |
Q4 2017 | $280,986,000 | +5.9% | 19,311,850 | +3.6% | 0.01% | 0.0% |
Q3 2017 | $265,334,000 | +11.5% | 18,646,082 | +0.0% | 0.01% | 0.0% |
Q2 2017 | $237,922,000 | +28.1% | 18,645,884 | +27.3% | 0.01% | +30.0% |
Q1 2017 | $185,724,000 | +14999.5% | 14,646,995 | +12058.5% | 0.01% | +400.0% |
Q4 2016 | $1,230,000 | -28.7% | 120,467 | -8.0% | 0.00% | 0.0% |
Q3 2016 | $1,726,000 | +14.7% | 130,988 | +10.6% | 0.00% | 0.0% |
Q2 2016 | $1,505,000 | +39.4% | 118,487 | +45.0% | 0.00% | 0.0% |
Q1 2016 | $1,080,000 | -2.5% | 81,739 | +13.5% | 0.00% | 0.0% |
Q4 2015 | $1,108,000 | +23.8% | 72,041 | -0.3% | 0.00% | +100.0% |
Q3 2015 | $895,000 | +3.9% | 72,281 | +14.8% | 0.00% | 0.0% |
Q2 2015 | $861,000 | +15.1% | 62,948 | +0.6% | 0.00% | 0.0% |
Q1 2015 | $748,000 | -80.5% | 62,593 | -79.2% | 0.00% | -80.0% |
Q4 2014 | $3,839,000 | +5307.0% | 300,646 | +5626.6% | 0.01% | – |
Q3 2014 | $71,000 | -16.5% | 5,250 | 0.0% | 0.00% | – |
Q2 2014 | $85,000 | -52.2% | 5,250 | -46.6% | 0.00% | – |
Q1 2014 | $178,000 | -44.5% | 9,840 | -52.6% | 0.00% | -100.0% |
Q4 2013 | $321,000 | +3.9% | 20,739 | -0.2% | 0.00% | 0.0% |
Q3 2013 | $309,000 | +10.0% | 20,786 | -4.1% | 0.00% | 0.0% |
Q2 2013 | $281,000 | – | 21,664 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |